Enyedy Mark J
SEC insider (Form 3/4/5 filer). CIK 0001586965. Director at BIOMARIN PHARMACEUTICAL INC (BMRN) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 2, 2026. Located in SAN RAFAEL, CA.
Companies Enyedy Mark J has filed insider reports for
- BIOMARIN PHARMACEUTICAL INC (BMRN): Director
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): Director
Enyedy Mark J
CIK: 0001586965
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 2, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
AwardDirect7.5K shares- - May 8, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
AwardDirect1.4K shares at avg. $177.62$255K - Jun 2, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
AwardDirect946 shares at avg. $135.04$128K - May 20, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
AwardDirect6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 2, 2026 |  BMRN BIOMARIN PHARMACEUTICAL INC | Award | 7,490 | - | $0 | Direct |
| May 8, 2026 |  CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award | 1,438 | $177.62 | $255,418 | Direct |
| Jun 2, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award | 946 | $135.04 | $127,748 | Direct |
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award | 6,650 | - | - | Direct |
1-4 of 4 transactions